Hosted on MSN
GSK Pharma Q3 results 2025: PAT ZOOMS 402% YoY, Revenue at Rs 949 cr - Check quarterly earnings
GSK Pharma Q3 results 2025: GlaxoSmithKline Pharma Ltd announced its Q3 results today posting a solid jump in its net profit. Consolidated PAT for the quarter surged by a robust 402 per cent. At the ...
Successful PAT implementation should start small, with the goal of integrating data into decision-making and fostering cross-functional collaboration.
Pharma major Sun Pharmaceuticals on Saturday reported a consolidated net profit of Rs 3,369 crore in the third quarter of FY26, marking a sharp 16% jump from Rs 2,903 crore it posted in the same ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results